180 related articles for article (PubMed ID: 18164362)
1. Anticancer activity of botanical alkyl hydroquinones attributed to topoisomerase II poisoning.
Huang CP; Fang WH; Lin LI; Chiou RY; Kan LS; Chi NH; Chen YR; Lin TY; Lin SB
Toxicol Appl Pharmacol; 2008 Mar; 227(3):331-8. PubMed ID: 18164362
[TBL] [Abstract][Full Text] [Related]
2. A cysteine-reactive alkyl hydroquinone modifies topoisomerase IIα, enhances DNA breakage, and induces apoptosis in cancer cells.
Lin TY; Huang CP; Au LC; Chang YW; Hu CY; Lin SB
Chem Res Toxicol; 2012 Nov; 25(11):2340-51. PubMed ID: 23088786
[TBL] [Abstract][Full Text] [Related]
3. Identification of an Alkylhydroquinone from Rhus succedanea as an Inhibitor of Tyrosinase and Melanogenesis.
Chen YR; Y-Y R; Lin TY; Huang CP; Tang WC; Chen ST; Lin SB
J Agric Food Chem; 2009 Mar; 57(6):2200-5. PubMed ID: 19159217
[TBL] [Abstract][Full Text] [Related]
4. E1A specifically enhances sensitivity to topoisomerase IIalpha targeting anticancer drug by up-regulating the promoter activity.
Zhou Z; Guan H; Kleinerman ES
Mol Cancer Res; 2005 May; 3(5):271-5. PubMed ID: 15886298
[TBL] [Abstract][Full Text] [Related]
5. Terpyridine-platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1.
Lo YC; Ko TP; Su WC; Su TL; Wang AH
J Inorg Biochem; 2009 Jul; 103(7):1082-92. PubMed ID: 19525010
[TBL] [Abstract][Full Text] [Related]
6. NK314, a novel topoisomerase II inhibitor, induces rapid DNA double-strand breaks and exhibits superior antitumor effects against tumors resistant to other topoisomerase II inhibitors.
Onda T; Toyoda E; Miyazaki O; Seno C; Kagaya S; Okamoto K; Nishikawa K
Cancer Lett; 2008 Jan; 259(1):99-110. PubMed ID: 17998154
[TBL] [Abstract][Full Text] [Related]
7. Differences in the longevity of topo IIalpha and topo IIbeta drug-stabilized cleavable complexes and the relationship to drug sensitivity.
Errington F; Willmore E; Leontiou C; Tilby MJ; Austin CA
Cancer Chemother Pharmacol; 2004 Feb; 53(2):155-62. PubMed ID: 14504921
[TBL] [Abstract][Full Text] [Related]
8. A three-dimensional quantitative structure-activity analysis of a new class of bisphenol topoisomerase IIalpha inhibitors.
Liang H; Wu X; Yalowich JC; Hasinoff BB
Mol Pharmacol; 2008 Mar; 73(3):686-96. PubMed ID: 18045852
[TBL] [Abstract][Full Text] [Related]
9. Thiol-modulated mechanisms of the cytotoxicity of thimerosal and inhibition of DNA topoisomerase II alpha.
Wu X; Liang H; O'Hara KA; Yalowich JC; Hasinoff BB
Chem Res Toxicol; 2008 Feb; 21(2):483-93. PubMed ID: 18197631
[TBL] [Abstract][Full Text] [Related]
10. The antileukemia activity of natural product HQ17(3) is possibly associated with downregulation of miR-17-92 cluster.
Liao YC; Lin TH; Chen CY; Lin SB; Au LC
Biomed Res Int; 2014; 2014():306718. PubMed ID: 25140305
[TBL] [Abstract][Full Text] [Related]
11. Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors.
Jensen LH; Thougaard AV; Grauslund M; Søkilde B; Carstensen EV; Dvinge HK; Scudiero DA; Jensen PB; Shoemaker RH; Sehested M
Cancer Res; 2005 Aug; 65(16):7470-7. PubMed ID: 16103101
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the action of the topoisomerase II poison amsacrine by simple aniline derivatives: evidence for drug-protein interactions.
Finlay GJ; Atwell GJ; Baguley BC
Oncol Res; 1999; 11(6):249-54. PubMed ID: 10691026
[TBL] [Abstract][Full Text] [Related]
13. Psammaplin A, a natural phenolic compound, has inhibitory effect on human topoisomerase II and is cytotoxic to cancer cells.
Kim D; Lee IS; Jung JH; Lee CO; Choi SU
Anticancer Res; 1999; 19(5B):4085-90. PubMed ID: 10628358
[TBL] [Abstract][Full Text] [Related]
14. A three-dimensional quantitative structure-activity relationship study of the inhibition of the ATPase activity and the strand passing catalytic activity of topoisomerase IIalpha by substituted purine analogs.
Jensen LH; Liang H; Shoemaker R; Grauslund M; Sehested M; Hasinoff BB
Mol Pharmacol; 2006 Nov; 70(5):1503-13. PubMed ID: 16880287
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by plumbagin through reactive oxygen species-mediated inhibition of topoisomerase II.
Kawiak A; Piosik J; Stasilojc G; Gwizdek-Wisniewska A; Marczak L; Stobiecki M; Bigda J; Lojkowska E
Toxicol Appl Pharmacol; 2007 Sep; 223(3):267-76. PubMed ID: 17618663
[TBL] [Abstract][Full Text] [Related]
16. A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity.
Huang H; Chen Q; Ku X; Meng L; Lin L; Wang X; Zhu C; Wang Y; Chen Z; Li M; Jiang H; Chen K; Ding J; Liu H
J Med Chem; 2010 Apr; 53(8):3048-64. PubMed ID: 20353152
[TBL] [Abstract][Full Text] [Related]
17. Lycobetaine acts as a selective topoisomerase II beta poison and inhibits the growth of human tumour cells.
Barthelmes HU; Niederberger E; Roth T; Schulte K; Tang WC; Boege F; Fiebig HH; Eisenbrand G; Marko D
Br J Cancer; 2001 Nov; 85(10):1585-91. PubMed ID: 11720449
[TBL] [Abstract][Full Text] [Related]
18. Salvicine functions as novel topoisomerase II poison by binding to ATP pocket.
Hu CX; Zuo ZL; Xiong B; Ma JG; Geng MY; Lin LP; Jiang HL; Ding J
Mol Pharmacol; 2006 Nov; 70(5):1593-601. PubMed ID: 16914642
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerase I and II inhibitors control caspase-2 pre-messenger RNA splicing in human cells.
Solier S; Lansiaux A; Logette E; Wu J; Soret J; Tazi J; Bailly C; Desoche L; Solary E; Corcos L
Mol Cancer Res; 2004 Jan; 2(1):53-61. PubMed ID: 14757846
[TBL] [Abstract][Full Text] [Related]
20. Alternariol acts as a topoisomerase poison, preferentially affecting the IIalpha isoform.
Fehr M; Pahlke G; Fritz J; Christensen MO; Boege F; Altemöller M; Podlech J; Marko D
Mol Nutr Food Res; 2009 Apr; 53(4):441-51. PubMed ID: 18727009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]